The combined presence of CD20+ B cells and PD-L1+ tumor infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome.

PURPOSE: To evaluate protein expression of PD-L1 and CD20 as prognostic biomarkers of patient outcome in inflammatory breast cancer (IBC) samples. METHODS: PD-L1 and CD20 protein expression was measured by immunohistochemistry in 221 pretreatment IBC biopsies. PD-L1 was assessed in tumor cells (PD-L...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Breast Cancer Res Treat
Hauptverfasser: Arias-Pulido, H., Cimino-Mathews, A., Chaher, N., Qualls, C., Joste, N., Colpaert, C., Marotti, J. D., Foisey, M., Prossnitz, E. R., Emens, L.A., Fiering, S.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2018
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6173952/
https://ncbi.nlm.nih.gov/pubmed/29858752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-018-4834-7
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge